Ticker
STOKCompany Name
STOKE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 199.89M | $ 28.98M | 14.5% |
3/31/2025 | $ 190.91M | $ 28.81M | 15.09% |
12/31/2024 | $ 36.55M | $ 27.47M | 75.15% |
9/30/2024 | $ 16.74M | $ 26.39M | 157.61% |
6/30/2024 | $ 15.16M | $ 25.45M | 167.89% |
3/31/2024 | $ 7.84M | $ 24.78M | 315.87% |
12/31/2023 | $ 8.78M | $ 25.26M | 287.67% |
9/30/2023 | $ 9.25M | $ 24.99M | 270.24% |
6/30/2023 | $ 8.84M | $ 24.36M | 275.47% |
3/31/2023 | $ 14.56M | $ 23.77M | 163.27% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for STOKE THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 4.9M ] / Revenues [ $ 0 ]
(=) SB Comp % [ 0% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 2.99K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |